Predictions
Ferroglobe plc
Start price
Target price
Perf. (%)
€1.48
04.12.20
04.12.20
-
04.12.21
04.12.21
251.35%
05.12.21
05.12.21
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.58
04.12.20
04.12.20
-
04.12.21
04.12.21
282.12%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gaussin S.A.
Start price
Target price
Perf. (%)
€11.20
03.12.20
03.12.20
€18.00
03.12.21
03.12.21
-39.55%
05.08.21
05.08.21
Could be very worthwhile Investment >20% year
Undervalued
Hexagon Composites ASA
Start price
Target price
Perf. (%)
€5.80
02.12.20
02.12.20
-
02.12.21
02.12.21
-12.07%
23.02.21
23.02.21
Business model of the past or high risk
Higher risks for its business
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Cellcom Israel Ltd
Start price
Target price
Perf. (%)
€3.76
02.12.20
02.12.20
-
02.12.21
02.12.21
6.38%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€11.72
02.12.20
02.12.20
-
02.12.21
02.12.21
-39.70%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Copper Mountain Mining Corp.
Start price
Target price
Perf. (%)
€1.02
02.12.20
02.12.20
-
02.12.21
02.12.21
138.24%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€46.50
01.12.20
01.12.20
€90.00
01.12.21
01.12.21
-27.97%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€202.00
30.11.20
30.11.20
€400.00
30.11.21
30.11.21
1.98%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.10
30.11.20
30.11.20
€14.00
30.11.21
30.11.21
-7.21%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.50
30.11.20
30.11.20
€15.00
30.11.21
30.11.21
31.85%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€21.00
30.11.20
30.11.20
€25.00
30.11.21
30.11.21
-15.71%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
30.11.20
30.11.20
€7.00
30.11.21
30.11.21
-
14.12.20
14.12.20
Could be very worthwhile Investment >20% year
Navios Maritime Holdings
Start price
Target price
Perf. (%)
€2.34
30.11.20
30.11.20
-
30.11.21
30.11.21
-16.24%
13.12.20
13.12.20
Risky Investment
Below average Marketposition
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.65
30.11.20
30.11.20
€10.50
30.11.21
30.11.21
-21.05%
14.12.20
14.12.20
Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€6.18
30.11.20
30.11.20
€8.00
30.11.21
30.11.21
-22.65%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Fair valuation
Capable Management
Risky balance sheet
2G Energy AG
Start price
Target price
Perf. (%)
€86.30
29.11.20
29.11.20
€105.00
29.11.21
29.11.21
-2.20%
10.12.20
10.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Inovio Pharma
Start price
Target price
Perf. (%)
€10.60
29.11.20
29.11.20
€12.00
29.11.21
29.11.21
-11.79%
10.12.20
10.12.20
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Matthews International Corp.
Start price
Target price
Perf. (%)
€22.60
29.11.20
29.11.20
-
29.11.21
29.11.21
-2.65%
12.12.20
12.12.20
StoneMor Inc.
Start price
Target price
Perf. (%)
€1.20
29.11.20
29.11.20
-
29.11.21
29.11.21
8.33%
12.12.20
12.12.20
Risky Investment